OSX-100

N/A

Report date: 2023/05/22 10:16:45
NME

Base Information

Drug NameOSX-100
Drug Alias NameOSX100
ClassificationSmall molecules
Mechanisms of ActionB-cell-activating factor/B lymphocyte stimulator inhibitors
TargetsB-cell-activating factor/B lymphocyte stimulator
Therapy Area/IndicationsMyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOssianix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOssianix Inc
Active IndicationsN/A
Inactive IndicationsMyositis

Other Information

ATC CodeN/A
Related LinksN/A